Holdings
Sphera Funds Management LTD.
As of Jun 30, 2026, Sphera Funds Management LTD. reported 86 positions worth US$612M. Largest: Teva Pharmaceutical Industries Limited, Mineralys Therapeutics, Inc. and Syndax Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Limited | 1.5M | US$50.8M | +363K | Jun 30, 2026 |
| Mineralys Therapeutics, Inc. | 1.47M | US$39.7M | +130K | Jun 30, 2026 |
| Syndax Pharmaceuticals, Inc. | 1.01M | US$22.2M | +290K | Jun 30, 2026 |
| Biogen Inc. | 96,626 | US$20.9M | +4,100 | Jun 30, 2026 |
| Ultragenyx Pharmaceutical Inc. | 588K | US$19.6M | −221K | Jun 30, 2026 |
| Biomarin Pharmaceutical Inc. | 329K | US$18.8M | +189K | Jun 30, 2026 |
| Cytokinetics, Incorporated | 220K | US$18.7M | +180K | Jun 30, 2026 |
| Bridgebio Pharma, Inc. | 245K | US$18.3M | +100 | Jun 30, 2026 |
| Cogent Biosciences, Inc. | 459K | US$17.8M | +43,000 | Jun 30, 2026 |
| Insmed Incorporated | 119K | US$12.7M | new | Jun 30, 2026 |